We used this value as an arbitrary cut-off to divide CLL samples into Jag1hi (Jag1-FL/GAPDH ratio ≥ 0.53) and Jag1low (<0.53) subgroups. This evidence concerns the gene GAPDH and B-cell chronic lymphocytic leukemia.